Singapore - English - HSA (Health Sciences Authority)

aenon pharmaceuticals sea pte. ltd. - japanese encephalitis virus strain sa₁₄-14-2 (inactivated) - injection, suspension - 6 μg/0.5 ml - japanese encephalitis virus strain sa₁₄-14-2 (inactivated) 6 μg/0.5 ml

European Union - English - EMA (European Medicines Agency)

valneva austria gmbh - japanese-encephalitis virus, inactivated (attenuated strain sa14-14-2 grown in vero cells) - encephalitis, japanese; immunization - vaccines - ixiaro is indicated for active immunisation against japanese encephalitis in adults, adolescents, children and infants aged two months and older.ixiaro should be considered for use in individuals at risk of exposure through travel or in the course of their occupation.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

valneva uk ltd - japanese encephalitis virus - suspension for injection

Israel - English - Ministry of Health

kamada ltd, israel - japanese encephalitis purified inactivated vaccine - suspension for injection - japanese encephalitis purified inactivated vaccine 6 au / 0.5 ml - encephalitis, japanese, inactivated, whole virus - ixiaro is indicated for active immunization against japanese encephalitis in adults, adolescents, children and infants aged 2 months and older. ixiaro should be considered for use in individuals at risk of exposure through travel or in the course of their occupation.

Canada - English - Health Canada

(biken) the res.found.for microb.dis.osaka university - japanese encephalitis virus vaccine, inactivated; water - powder for suspension - 1unit; 1.3ml - japanese encephalitis virus vaccine, inactivated 1unit; water 1.3ml - vaccines

Canada - English - Health Canada

valneva austria gmbh - inact.japanese encephal virus(attenuat. strain sa14-14-2 produced in vero cells) - suspension - 6mcg - inact.japanese encephal virus(attenuat. strain sa14-14-2 produced in vero cells) 6mcg - vaccines

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (korea) - japanese encephalitis virus - solution for injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (korea) - japanese encephalitis virus - solution for injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (korea) - japanese encephalitis virus - solution for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - japanese encephalitis vaccine 6 units - suspension for injection - 6 u/dose - active: japanese encephalitis vaccine 6 units excipient: aluminium hydroxide gel dibasic sodium phosphate monobasic potassium phosphate sodium chloride - jespect® is indicated for active immunisation against japanese encephalitis (je) virus for persons 18 years of age and older. jespect® should be considered for use in persons who plan to reside in or travel to areas where je is endemic (common) or epidemic (seasonal), especially during the transmission season. jespect® is indicated for persons who work with je virus in laboratories and in industry.